Form D — CHARM Therapeutics Inc.
0001231919-25-000181 · filed Sep 3, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Other filings
Offering
- Industry
- Other
- Exemptions
- Rule 506(b)
- Reported offering amount
- $80,095,754
- Reported amount sold
- $17,290,119
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- CHARM Therapeutics Inc.
- CIK
- 1889676
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 7 PANCRAS SQUARE
LONDON, United Kingdom N1C 4AG - Phone
- 447582703655
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gary Glick · Executive OfficerLONDON, United Kingdom Find on LinkedIn ↗
-
Rishi Gupta · DirectorLONDON, United Kingdom Find on LinkedIn ↗
-
Nihal Sinha · DirectorLONDON, United Kingdom Find on LinkedIn ↗
-
Matthew McAviney · DirectorLONDON, United Kingdom Find on LinkedIn ↗
-
Mahesh Kudari · DirectorLONDON, United Kingdom Find on LinkedIn ↗
-
Briggs Morrison · DirectorLONDON, United Kingdom Find on LinkedIn ↗
-
Kim Blackwell · DirectorLONDON, United Kingdom Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗